W81K0016T0067.pdf

SEE ADDENDUM

(No Collect Calls)

W81K00-16-T-0067 12-May-2016

b. TELEPHONE NUMBER

254-285-6747

8. OFFER DUE DATE/LOCAL TIME

11:00 AM 13 Jun 2016

5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

AUTHORIZED FOR LOCAL REPRODUCTION

PREVIOUS EDITION IS NOT USABLE

STANDARD FORM 1449 (REV. 2/2012)

Prescribed by GSA – FAR (48 CFR) 53.212

(TYPE OR PRINT)

(SIGNATURE OF CONTRACTING OFFICER)

ADDENDA ARE

26. TOTAL AWARD AMOUNT (For Gov t. Use Only )

23.

CODE 10. THIS ACQUISITION IS

SUCH ADDRESS IN OFFER

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT

BELOW IS CHECKED

TELEPHONE NO.

W81K009. ISSUED BY

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a. UNLESS BLOCK

7. FOR SOLICITATION

INFORMATION CALL:

a. NAME

TIMOTHY T. HOERZ

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NUMBER

(TYPE OR PRINT)

30b. NAME AND TITLE OF SIGNER 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a.UNITED STATES OF AMERICA

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1. 52.212-4. FAR 52.212-3. 52.212-5 ARE ATTACHED.

25. ACCOUNTING AND APPROPRIATION DATA

1. REQUISITION NUMBER

20.

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED.

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, AND 30

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS

0010855083

ARE NOT ATTACHED

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

SET FORTH HEREIN, IS ACCEPTED AS TO ITEMS:

. YOUR OFFER ON SOLICITATION

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN

% FOR:SET ASIDE:UNRESTRICTED OR X

SMALL BUSINESSX

17a.CONTRACTOR/ CODE FACILITY

OFFEROR CODE

W40M USA MEDCOM HCAA

SOUTHERN REG CONTR OFC

3551 ROGER BROOK DR BLDG 3600

FORT SAM HOUSTON TX 78234-6200

18a. PAYMENT WILL BE MADE BY CODE

RATED ORDER UNDER

DPAS (15 CFR 700)

13a. THIS CONTRACT IS A

13b. RATING

CODE15. DELIVER TO CODE W45XTR 16. ADMINISTERED BY

12. DISCOUNT TERMS11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

14. METHOD OF SOLICITATION

RFQ IFB RFPX

W2M5 CARL R DARNELL ARMY MED C

W2M5 CARL R DARNALL ARMY MED C

MEDICAL SUPPLY OFFICER DACH

BLDG 36065 SANTE FE AVE

FORT HOOD TX 76544-5063

TEL: 210-221-7141 FAX:

FAX:

TEL: SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

8(A)

HUBZONE SMALL

BUSINESS

SIZE STANDARD:

NAICS:

325412

X

OFFER DATED

29. AWARD OF CONTRACT: REF.

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND

EMAIL:

TEL:

31c. DATE SIGNED

SEE SCHEDULE

SCHEDULE OF SUPPLIES/ SERVICESITEM NO. QUANTITY UNIT UNIT PRICE AMOUNT

24.22.21.19.

WOMEN-OWNED SMALL BUSINESS (WOSB)

ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

32g. E-MAIL OF AUTHORIZED GOVERNMENT REPRESENTATIVE

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS

(CONTINUED)

PAGE 2 OF76

ACCEPTED, AND CONFORMS TO THE CONTRACT, EXCEPT AS NOTED: ______________________________________________________

32a. QUANTITY IN COLUMN 21 HAS BEEN

RECEIVED INSPECTED

32b. SIGNATURE OF AUTHORIZED GOVERNMENT

REPRESENTATIVE

32c. DATE 32d. PRINTED NAME AND TITLE OF AUTHORIZED GOVERNMENT

REPRESENTATIVE

32e. MAILING ADDRESS OF AUTHORIZED GOVERNMENT REPRESENTATIVE 32f . TELEPHONE NUMBER OF AUTHORIZED GOVERNMENT REPRESENTATIVE

37. CHECK NUMBER

FINALPARTIALCOMPLETE

36. PAYMENT35. AMOUNT VERIFIED

CORRECT FOR

34. VOUCHER NUMBER

FINAL

33. SHIP NUMBER

PARTIAL

38. S/R ACCOUNT NUMBER 39. S/R VOUCHER NUMBER 40. PAID BY

41a. I CERTIFY THIS ACCOUNT IS CORRECT AND PROPER FOR PAYMENT

41b. SIGNATURE AND TITLE OF CERTIFYING OFFICER 41c. DATE

42a. RECEIVED BY (Print)

42b. RECEIVED AT (Location)

42c. DATE REC'D (YY/MM/DD) 42d. TOTAL CONTAINERS

STANDARD FORM 1449 (REV. 2/2012) BACK

Prescribed by GSA – FAR (48 CFR) 53.212

AUTHORIZED FOR LOCAL REPRODUCTION

PREVIOUS EDITION IS NOT USABLE

SEE SCHEDULE

20.

SCHEDULE OF SUPPLIES/ SERVICES

21.

QUANTITY UNIT

22. 23.

UNIT PRICE

24.

AMOUNT

19.

ITEM NO.

W81K00-16-T-0067

Section SF 1449 - CONTINUATION SHEET

ITEM NO SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

Base Year - Compounded Pharmaceuticals

FFP

Pharmaceuticals will be ordered on an as needed basis by a Government Ordering

Officer. See Addendum to FAR 52.212-2 for details. POP 1 July 2016 to 30

September 2017.

FOB: Destination

NET AMT

0001AA 260 Each Hydromorphone 0.2mg/ml 30ml PCA

FFP

Hydromorphone 0.2mg/ml 30ml PCA. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. See FAR Addendum 52.212-2 for details.

PURCHASE REQUEST NUMBER: 0010855083

0001AB 1,600 Each Succinylcholine 20mg/ml in 5ml syringe

FFP

Succinylcholine 20mg/ml in 5ml syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. See FAR Addendum 52.212-2 for details.

0001AC 1,200 Each Ephedrine 5mg/ml in 0.9% NaCI 5ml Syring

FFP

Ephedrine 5mg/ml in 0.9% NaCI 5ml Syring. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. See FAR Addendum 52.212-2 for details.

0001AD 150 Each Fenanyl 50mcg/ml in 50ml bag

FFP

Fenanyl 50mcg/ml in 50ml bag. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. See FAR Addendum 52.212-2 for details.

0001AE 125 Each Ketamine 50mg/ml in 5ml syringe

FFP

Ketamine 50mg/ml in 5ml syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. See FAR Addendum 52.212-2 for details.

0001AF 1,000 Each Ropivacaine 0.2% in 100ml CADD Cassette

FFP

Ropivacaine 0.2% in 100ml CADD Cassette. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. See FAR Addendum 52.212-2 for details.

0001AG 150 Each Lidocaine, Epinephrine, Tetracaine LET

FFP

Lidocaine, Epinephrine, Tetracaine LET. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. See FAR Addendum 52.212-2 for details.

0001AH 180 Each Progesterone 50mg suppository

FFP

Progesterone 50mg suppository. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. See FAR Addendum 52.212-2 for details.

0001AJ 2,400 Each Oxytocin 30units in 500ml lactated syrin

FFP

Oxytocin 30units in 500ml lactated syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. See FAR Addendum 52.212-2 for details.

0001AK 250 Each Ropivacaine 0.2% with Fentanyl 2mcg/ml

FFP

Fentanyl Citrate (USP) 2mcg/ml with 0.2% Ropivacaine HCI (USP) 100ML

Yellow CADD Cassette. Pharmaceuticals will be ordered on a as needed basis by

Government Ordering Officer. See FAR Addendum 52.212-2 for details.

OPTION 1st Option - Compounded Pharmaceuticals

FFP

Pharmaceuticals will be ordered on an as needed basis by a Government Ordering

Officer. See Addendum to FAR 52.212-2 for details. Subject to availabilty of

FY17 funds see FAR Clause 52.232-18. POP 1 October 2016 to 30 September

2017.

1001AA 520 Each OPTION Hydromorphone 0.2mg/ml 30ml PCA

FFP

Hydromorphone 0.2mg/ml 30ml PCA. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY17 funds see FAR Clause 52.232-18. See FAR Addendum 52.212-2 for details.

1001AB 3,200 Each OPTION Succinylcholine 20mg/ml in 5ml syringe

FFP

Succinylcholine 20mg/ml in 5ml syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY17

1001AC 2,400 Each OPTION Ephedrine 5mg/ml in 0.9% NaCI 5ml Syring

FFP

Ephedrine 5mg/ml in 0.9% NaCI 5ml Syring. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY17

1001AD 300 Each OPTION Fenanyl 50mcg/ml in 50ml bag

FFP

Fenanyl 50mcg/ml in 50ml bag. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY17 funds see

FAR Clause 52.232-18. See FAR Addendum 52.212-2 for details.

1001AE 250 Each OPTION Ketamine 50mg/ml in 5ml syringe

FFP

Ketamine 50mg/ml in 5ml syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY17 funds see

1001AF 2,000 Each OPTION Ropivacaine 0.2% in 100ml CADD Cassette

FFP

Ropivacaine 0.2% in 100ml CADD Cassette. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY17

1001AG 300 Each OPTION Lidocaine, Epinephrine, Tetracaine LET

FFP

Lidocaine, Epinephrine, Tetracaine LET. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY17

1001AH 360 Each OPTION Progesterone 50mg suppository

FFP

Progesterone 50mg suppository. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY17 funds see

1001AJ 4,800 Each OPTION Oxytocin 30units in 500ml lactated syrin

FFP

Oxytocin 30units in 500ml lactated syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY17

1001AK 500 Each OPTION Ropivacaine 0.2% with Fentanyl 2mcg/ml

FFP

Fentanyl Citrate (USP) 2mcg/ml with 0.2% Ropivacaine HCI (USP) 100ML

Yellow CADD Cassette. Pharmaceuticals will be ordered on a as needed basis by

Government Ordering Officer. Subject to availabilty of FY17 funds see FAR

Clause 52.232-18. See FAR Addendum 52.212-2 for details.

OPTION 2nd Option - Compounded Pharmaceuticals

FFP

Pharmaceuticals will be ordered on an as needed basis by a Government Ordering

Officer. See Addendum to FAR 52.212-2 for details. Subject to availabilty of

FY18 funds see FAR Clause 52.232-18. POP 1 October 2017 to 30 September

2018.

2001AA 520 Each OPTION Hydromorphone 0.2mg/ml 30ml PCA

FFP

Hydromorphone 0.2mg/ml 30ml PCA. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY18

2001AB 3,200 Each OPTION Succinylcholine 20mg/ml in 5ml syringe

FFP

Succinylcholine 20mg/ml in 5ml syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY18

2001AC 2,400 Each OPTION Ephedrine 5mg/ml in 0.9% NaCI 5ml Syring

FFP

Ephedrine 5mg/ml in 0.9% NaCI 5ml Syring. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY18

2001AD 300 Each OPTION Fenanyl 50mcg/ml in 50ml bag

FFP

Fenanyl 50mcg/ml in 50ml bag. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY18 funds see

2001AE 250 Each OPTION Ketamine 50mg/ml in 5ml syringe

FFP

Ketamine 50mg/ml in 5ml syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY18 funds see

2001AF 2,000 Each OPTION Ropivacaine 0.2% in 100ml CADD Cassette

FFP

Ropivacaine 0.2% in 100ml CADD Cassette. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY18

2001AG 300 Each OPTION Lidocaine, Epinephrine, Tetracaine LET

FFP

Lidocaine, Epinephrine, Tetracaine LET. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY18

2001AH 360 Each OPTION Progesterone 50mg suppository

FFP

Progesterone 50mg suppository. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY18 funds see

2001AJ 4,800 Each OPTION Oxytocin 30units in 500ml lactated syrin

FFP

Oxytocin 30units in 500ml lactated syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY18

2001AK 500 Each OPTION Ropivacaine 0.2% with Fentanyl 2mcg/ml

FFP

Fentanyl Citrate (USP) 2mcg/ml with 0.2% Ropivacaine HCI (USP) 100ML

Yellow CADD Cassette. Pharmaceuticals will be ordered on a as needed basis by

Government Ordering Officer. Subject to availabilty of FY18 funds see FAR

OPTION 3rd Option - Compounded Pharmaceuticals

FFP

Pharmaceuticals will be ordered on an as needed basis by a Government Ordering

Officer. See Addendum to FAR 52.212-2 for details. Subject to availabilty of

FY19 funds see FAR Clause 52.232-18. POP 1 October 2018 to 30 September

2019.

3001AA 520 Each OPTION Hydromorphone 0.2mg/ml 30ml PCA

FFP

Hydromorphone 0.2mg/ml 30ml PCA. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY19

3001AB 3,200 Each OPTION Succinylcholine 20mg/ml in 5ml syringe

FFP

Succinylcholine 20mg/ml in 5ml syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY19

3001AC 2,400 Each OPTION Ephedrine 5mg/ml in 0.9% NaCI 5ml Syring

FFP

Ephedrine 5mg/ml in 0.9% NaCI 5ml Syring. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY19

3001AD 300 Each OPTION Fenanyl 50mcg/ml in 50ml bag

FFP

Fenanyl 50mcg/ml in 50ml bag. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY19 funds see

3001AE 250 Each OPTION Ketamine 50mg/ml in 5ml syringe

FFP

Ketamine 50mg/ml in 5ml syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY19 funds see

3001AF 2,000 Each OPTION Ropivacaine 0.2% in 100ml CADD Cassette

FFP

Ropivacaine 0.2% in 100ml CADD Cassette. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY19

3001AG 300 Each OPTION Lidocaine, Epinephrine, Tetracaine LET

FFP

Lidocaine, Epinephrine, Tetracaine LET. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY19

3001AH 360 Each OPTION Progesterone 50mg suppository

FFP

Progesterone 50mg suppository. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY19 funds see

3001AJ 4,800 Each OPTION Oxytocin 30units in 500ml lactated syrin

FFP

Oxytocin 30units in 500ml lactated syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY19

3001AK 500 Each OPTION Ropivacaine 0.2% with Fentanyl 2mcg/ml

FFP

Fentanyl Citrate (USP) 2mcg/ml with 0.2% Ropivacaine HCI (USP) 100ML

Yellow CADD Cassette. Pharmaceuticals will be ordered on a as needed basis by

Government Ordering Officer. Subject to availabilty of FY19 funds see FAR

OPTION 4th Option - Compounded Pharmaceuticals

FFP

Pharmaceuticals will be ordered on an as needed basis by a Government Ordering

Officer. See Addendum to FAR 52.212-2 for details. Subject to availabilty of

FY20 funds see FAR Clause 52.232-18. POP 1 October 2019 to 30 September

2020.

4001AA 520 Each OPTION Hydromorphone 0.2mg/ml 30ml PCA

FFP

Hydromorphone 0.2mg/ml 30ml PCA. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY20

4001AB 3,200 Each OPTION Succinylcholine 20mg/ml in 5ml syringe

FFP

Succinylcholine 20mg/ml in 5ml syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY20

4001AC 2,400 Each OPTION Ephedrine 5mg/ml in 0.9% NaCI 5ml Syring

FFP

Ephedrine 5mg/ml in 0.9% NaCI 5ml Syring. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY20

4001AD 300 Each OPTION Fenanyl 50mcg/ml in 50ml bag

FFP

Fenanyl 50mcg/ml in 50ml bag. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY20 funds see

4001AE 250 Each OPTION Ketamine 50mg/ml in 5ml syringe

FFP

Ketamine 50mg/ml in 5ml syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY20 funds see

4001AF 2,000 Each OPTION Ropivacaine 0.2% in 100ml CADD Cassette

FFP

Ropivacaine 0.2% in 100ml CADD Cassette. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY20

4001AG 300 Each OPTION Lidocaine, Epinephrine, Tetracaine LET

FFP

Lidocaine, Epinephrine, Tetracaine LET. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY20

4001AH 360 Each OPTION Progesterone 50mg suppository

FFP

Progesterone 50mg suppository. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY20 funds see

4001AJ 4,800 Each OPTION Oxytocin 30units in 500ml lactated syrin

FFP

Oxytocin 30units in 500ml lactated syringe. Pharmaceuticals will be ordered on a as needed basis by Government Ordering Officer. Subject to availabilty of FY20

4001AK 500 Each OPTION Ropivacaine 0.2% with Fentanyl 2mcg/ml

FFP

Fentanyl Citrate (USP) 2mcg/ml with 0.2% Ropivacaine HCI (USP) 100ML

Yellow CADD Cassette. Pharmaceuticals will be ordered on a as needed basis by

Government Ordering Officer. Subject to availabilty of FY20 funds see FAR

INSPECTION AND ACCEPTANCE TERMS

Supplies/services will be inspected/accepted at:

CLIN INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY

0001 Destination Government Destination Government

0001AA Destination Government Destination Government

0001AB Destination Government Destination Government

0001AC Destination Government Destination Government

0001AD Destination Government Destination Government

0001AE Destination Government Destination Government

0001AF Destination Government Destination Government

0001AG Destination Government Destination Government

0001AH Destination Government Destination Government

0001AJ Destination Government Destination Government

0001AK Destination Government Destination Government

1001 Destination Government Destination Government

1001AA Destination Government Destination Government

1001AB Destination Government Destination Government

1001AC Destination Government Destination Government

1001AD Destination Government Destination Government

1001AE Destination Government Destination Government

1001AF Destination Government Destination Government

1001AG Destination Government Destination Government

1001AH Destination Government Destination Government

1001AJ Destination Government Destination Government

1001AK Destination Government Destination Government

2001 Destination Government Destination Government

2001AA Destination Government Destination Government

2001AB Destination Government Destination Government

2001AC Destination Government Destination Government

2001AD Destination Government Destination Government

2001AE Destination Government Destination Government

2001AF Destination Government Destination Government

2001AG Destination Government Destination Government

2001AH Destination Government Destination Government

2001AJ Destination Government Destination Government

2001AK Destination Government Destination Government

3001 Destination Government Destination Government

3001AA Destination Government Destination Government

3001AB Destination Government Destination Government

3001AC Destination Government Destination Government

3001AD Destination Government Destination Government

3001AE Destination Government Destination Government

3001AF Destination Government Destination Government

3001AG Destination Government Destination Government

3001AH Destination Government Destination Government

3001AJ Destination Government Destination Government

3001AK Destination Government Destination Government

4001 Destination Government Destination Government

4001AA Destination Government Destination Government

4001AB Destination Government Destination Government

4001AC Destination Government Destination Government

4001AD Destination Government Destination Government

4001AE Destination Government Destination Government

4001AF Destination Government Destination Government

4001AG Destination Government Destination Government

4001AH Destination Government Destination Government

4001AJ Destination Government Destination Government

4001AK Destination Government Destination Government

DELIVERY INFORMATION

CLIN DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC

0001 N/A N/A N/A N/A

0001AA POP 01-JUL-2016 TO

30-SEP-2016

N/A W2M5 CARL R DARNELL ARMY MED C

W2M5 CARL R DARNALL ARMY MED C

MEDICAL SUPPLY OFFICER DACH

BLDG 36065 SANTE FE AVE

FORT HOOD TX 76544-5063

210-221-7141

W45XTR

0001AB POP 01-JUL-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

0001AC POP 01-JUL-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

0001AD POP 01-JUL-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

0001AE POP 01-JUL-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

0001AF POP 01-JUL-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

0001AG POP 01-JUL-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

0001AH POP 01-JUL-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

0001AJ POP 01-JUL-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

0001AK POP 01-JUL-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

1001 N/A N/A N/A N/A

1001AA POP 01-OCT-2016 TO

30-SEP-2017

N/A W2M5 CARL R DARNELL ARMY MED C

W2M5 CARL R DARNALL ARMY MED C

MEDICAL SUPPLY OFFICER DACH

BLDG 36065 SANTE FE AVE

FORT HOOD TX 76544-5063

210-221-7141

1001AB POP 01-OCT-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

1001AC POP 01-OCT-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

1001AD POP 01-OCT-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

1001AE POP 01-OCT-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

1001AF POP 01-OCT-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

1001AG POP 01-OCT-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

1001AH POP 01-OCT-2016 TO

01-SEP-2017

N/A (SAME AS PREVIOUS LOCATION)

1001AJ POP 01-OCT-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

1001AK POP 01-OCT-2016 TO

N/A (SAME AS PREVIOUS LOCATION)

2001 N/A N/A N/A N/A

2001AA POP 01-OCT-2017 TO

30-SEP-2018

N/A W2M5 CARL R DARNELL ARMY MED C

W2M5 CARL R DARNALL ARMY MED C

MEDICAL SUPPLY OFFICER DACH

BLDG 36065 SANTE FE AVE

FORT HOOD TX 76544-5063

210-221-7141

2001AB POP 01-OCT-2017 TO

N/A (SAME AS PREVIOUS LOCATION)

2001AC POP 01-OCT-2017 TO

N/A (SAME AS PREVIOUS LOCATION)

2001AD POP 01-OCT-2017 TO

N/A (SAME AS PREVIOUS LOCATION)

2001AE POP 01-OCT-2017 TO

N/A (SAME AS PREVIOUS LOCATION)

2001AF POP 01-OCT-2017 TO

N/A (SAME AS PREVIOUS LOCATION)

2001AG POP 01-OCT-2017 TO

N/A (SAME AS PREVIOUS LOCATION)

2001AH POP 01-OCT-2017 TO

N/A (SAME AS PREVIOUS LOCATION)

2001AJ POP 01-OCT-2017 TO

N/A (SAME AS PREVIOUS LOCATION)

2001AK POP 01-OCT-2017 TO

N/A (SAME AS PREVIOUS LOCATION)

3001 N/A N/A N/A N/A

3001AA POP 01-OCT-2018 TO

30-SEP-2019

N/A W2M5 CARL R DARNELL ARMY MED C

W2M5 CARL R DARNALL ARMY MED C

MEDICAL SUPPLY OFFICER DACH

BLDG 36065 SANTE FE AVE

FORT HOOD TX 76544-5063

210-221-7141

3001AB POP 01-OCT-2018 TO

01-SEP-2019

N/A (SAME AS PREVIOUS LOCATION)

3001AC POP 01-OCT-2018 TO

N/A (SAME AS PREVIOUS LOCATION)

3001AD POP 01-OCT-2018 TO

N/A (SAME AS PREVIOUS LOCATION)

3001AE POP 01-OCT-2018 TO

N/A (SAME AS PREVIOUS LOCATION)

3001AF POP 01-OCT-2018 TO

N/A (SAME AS PREVIOUS LOCATION)

3001AG POP 01-OCT-2018 TO

N/A (SAME AS PREVIOUS LOCATION)

3001AH POP 01-OCT-2018 TO

N/A (SAME AS PREVIOUS LOCATION)

3001AJ POP 01-OCT-2018 TO

N/A (SAME AS PREVIOUS LOCATION)

3001AK POP 01-OCT-2018 TO

N/A (SAME AS PREVIOUS LOCATION)

4001 N/A N/A N/A N/A

4001AA POP 01-OCT-2019 TO

30-SEP-2020

N/A W2M5 CARL R DARNELL ARMY MED C

W2M5 CARL R DARNALL ARMY MED C

MEDICAL SUPPLY OFFICER DACH

BLDG 36065 SANTE FE AVE

FORT HOOD TX 76544-5063

210-221-7141

4001AB POP 01-OCT-2019 TO

N/A (SAME AS PREVIOUS LOCATION)

4001AC POP 01-OCT-2019 TO

N/A (SAME AS PREVIOUS LOCATION)

4001AD POP 01-OCT-2019 TO

N/A (SAME AS PREVIOUS LOCATION)

4001AE POP 01-OCT-2019 TO

N/A (SAME AS PREVIOUS LOCATION)

4001AF POP 01-OCT-2019 TO

N/A (SAME AS PREVIOUS LOCATION)

4001AG POP 01-OCT-2019 TO

N/A (SAME AS PREVIOUS LOCATION)

4001AH POP 01-OCT-2019 TO

N/A (SAME AS PREVIOUS LOCATION)

4001AJ POP 01-OCT-2019 TO

N/A (SAME AS PREVIOUS LOCATION)

4001AK POP 01-OCT-2019 TO

N/A (SAME AS PREVIOUS LOCATION)

CLAUSES INCORPORATED BY REFERENCE

52.212-4 Contract Terms and Conditions--Commercial Items MAY 2015

CLAUSES INCORPORATED BY FULL TEXT

ADDENDUM TO 52.212-4

(w) The non-FAR Part 12 discretionary FAR, DFARS, AFARS, and LOCAL clauses included herein are incorporated into this contract either by reference or in full text. If incorporated by reference, see clause 52.252-2 herein for locations where full text can be found.

(End of Clause)

CLAUSES INCORPORATED BY REFERENCE

52.203-3 Gratuities APR 1984

52.203-6 Restrictions On Subcontractor Sales To The Government SEP 2006

52.203-6 Alt I Restrictions On Subcontractor Sales To The Government

(Sep 2006) -- Alternate I

OCT 1995

52.203-12 Limitation On Payments To Influence Certain Federal

Transactions

OCT 2010

52.203-17 Contractor Employee Whistleblower Rights and Requirement

To Inform Employees of Whistleblower Rights

APR 2014

52.204-4 Printed or Copied Double-Sided on Postconsumer Fiber

Content Paper

MAY 2011

52.204-10 Reporting Executive Compensation and First-Tier

Subcontract Awards

OCT 2015

52.209-6 Protecting the Government's Interest When Subcontracting

With Contractors Debarred, Suspended, or Proposed for

Debarment

OCT 2015

52.219-4 Notice of Price Evaluation Preference for HUBZone Small

Business Concerns

OCT 2014

52.219-6 Notice Of Total Small Business Set-Aside NOV 2011

52.219-8 Utilization of Small Business Concerns OCT 2014

52.219-9 Small Business Subcontracting Plan OCT 2015

52.219-14 Limitations On Subcontracting NOV 2011

52.219-16 Liquidated Damages-Subcontracting Plan JAN 1999

52.222-3 Convict Labor JUN 2003

52.222-19 Child Labor -- Cooperation with Authorities and Remedies FEB 2016

52.222-35 Equal Opportunity for Veterans OCT 2015

52.222-36 Equal Opportunity for Workers with Disabilities JUL 2014

52.222-37 Employment Reports on Veterans FEB 2016

52.222-50 Combating Trafficking in Persons MAR 2015

52.223-18 Encouraging Contractor Policies To Ban Text Messaging

While Driving

AUG 2011

52.225-13 Restrictions on Certain Foreign Purchases JUN 2008

52.232-18 Availability Of Funds APR 1984

52.232-33 Payment by Electronic Funds Transfer--System for Award

Management

JUL 2013

52.232-39 Unenforceability of Unauthorized Obligations JUN 2013

52.232-40 Providing Accelerated Payments to Small Business

Subcontractors

DEC 2013

52.233-3 Protest After Award AUG 1996

52.233-4 Applicable Law for Breach of Contract Claim OCT 2004

52.242-13 Bankruptcy JUL 1995

252.203-7000 Requirements Relating to Compensation of Former DoD

Officials

SEP 2011

252.203-7002 Requirement to Inform Employees of Whistleblower Rights SEP 2013

252.204-7003 Control Of Government Personnel Work Product APR 1992

252.209-7004 Subcontracting With Firms That Are Owned or Controlled By

The Government of a Country that is a State Sponsor of

Terrorism

OCT 2015

252.225-7012 Preference For Certain Domestic Commodities FEB 2013

252.225-7021 Trade Agreements--Basic (OCT 2015) OCT 2015

252.225-7048 Export-Controlled Items JUN 2013

252.232-7003 Electronic Submission of Payment Requests and Receiving

Reports

JUN 2012

252.232-7010 Levies on Contract Payments DEC 2006

252.243-7001 Pricing Of Contract Modifications DEC 1991

252.243-7002 Requests for Equitable Adjustment DEC 2012

52.212-1 Instructions to Offerors--Commercial Items OCT 2015

CLAUSES INCORPORATED BY FULL TEXT

ADDENDUM TO 52.212-1

Offeror shall submit signed and dated quotes to Regional Health Contracting Office - Central office (RHCO-C) no later than the date and time specified in Block 8, of the Standard Form 1449, Solicitation/Contract/Order for

Commercial Items. The quote shall have a title page identifying the offeror, the full address, phone and facsimile numbers, points of contact (POCs) of the offeror, the solicitation number and its contents.

Note: Facsimile offer and electronic (e-mail) offer is also acceptable, provided they meet the requirements listed above. E-mail is the preferred method.

Offer shall clearly identify each part of their quote, as described below.

Administrative:

a. Request for Quotes. The offeror shall include a copy of the completed SF 1449, with the signature and include the name of the offeror, address, phone and fax numbers in Block 17a.

b. The offeror shall submit a completed copy of FAR 52.212-3, Representations and Certifications –

Commercial Items. If the offeror has completed the Online Representations and Certifications Application

(ORCA) at https://www.uscontractorregistration.com/ the offeror shall indicate such on the FAR clause.

DFARS 252.212-7000, Offeror Representations and Certifications – Commercial Items. All offerors must https://www.uscontractorregistration.com/ be registered in the System for Award Management (SAM) prior to award, and lack of registration shall make an offer ineligible for award

Pricing:

a. Pricing for Requirements. The offeror shall submit quote pricing for all subContract Line Item Numbers

(subCLINs) identified in the Request for Proposal, unless otherwise noted. Include the unit price and the total extended price for each subCLIN.

b. Include shipping, if any or enter $0.00 on the shipping subCLIN.

Technical:

a. The technical quote shall be addressed in sufficient written detail for the Government to determine if the offeror’s product(s) adequately perform the specific requirements as stated in 52.212-2.

b. Offeror must meet the salient physical, functional, or performance characteristic specified in this solicitation and clearly describes any modification the offeror plans to make in a product to make it conform to the solicitation requirements. Mark any descriptive material to clearly show the modification

Special Delivery Mail.

a. Offeror is cautioned that the United States Postal Service (USPS) does not deliver directly to the Regional

Health Contracting Office - Central, CRDAMC Cell. All USPS mail is delivered to a central location at

Carl R. Darnall Army Medical Center. Offer should be sent in sufficient time to ensure arrival at the contracting office by the specified date and time. Offeror should consider the additional time needed for mail distribution when preparing their offers.

b. Offeror may drop-off their proposal at the Regional Health Contracting Office - Central, CRDAMC Cell prior to the specified due date and time. For directions to the contracting office, contact Timothy Hoerz timothy.t.hoerz.civ@mail.mil

(m) The non-FAR Part 12 discretionary FAR, DFARS, AFARS, and LOCAL provisions included herein are incorporated into this solicitation either by reference or in full text. If incorporated by reference, see provision

52.252-1 herein for locations where full text can be found.

(End of Provision)

52.212-2 EVALUATION--COMMERCIAL ITEMS (OCT 2014)

(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:

See Addendum to FAR 52.12-2

Award will be made using the lowest-price, technically-acceptable source selection process.

(b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s).

mailto:timothy.t.hoerz.civ@mail.mil

(c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.

(End of provision)

HCAA Local Clause 5005 (LPTA)

ADDENDUM TO 52.212-2

Award will be made using the lowest price technically acceptable (LPTA) source selection process. Award will be made to the responsible offeror on the basis of the lowest evaluated price of proposals meeting or exceeding the acceptability standards for non-cost factors. Award may be made without discussions with offerors (except communications conducted for the purpose of minor clarification). Therefore, each initial offer should contain the offeror's best terms from a technical and price standpoint. However, the Government reserves the right to conduct discussions if it is later determined by the contracting officer to be necessary.

(a). The Government will award a Purchase Order resulting from this solicitation, to the responsible Request For

Quote (RFQ) conforming to the solicitation, that is lowest price technically acceptable (LPTA). Award will be on an all or none basis. The following evaluation factors shall be used to evaluate offers: Technical Acceptability, Past

Performance, and Price.

EVALUATION PROCESS:

Award will be made using the lowest-price, technically-acceptable source selection process. The Government will initially list proposals from lowest to highest price. The Government will evaluate the lowest priced proposal first.

If that proposal is determined technically unacceptable, the Government will evaluate the next lowest priced proposal and continue in that manner until a proposal is rated Technically Acceptable. If a proposal is rated

Technically Unacceptable, the Government will not evaluate any other factor. USING THIS PROCEDURE, THE

GOVERNMENT MIGHT NOT EVALUATE ALL PROPOSALS.

The following evaluation factors shall be used to evaluate offers:

1. Technical Acceptability: Offer will be found technically acceptable if the offer meets the salient characteristics and all of the factors listed below.

In order to meet and maintain the high quality standards of Carl R. Darnall, a list of the necessary elements of compliance have been compiled. The requirements for patient specific prescriptions such as those compounded by local pharmacies do not meet specifications required for bulk compounds. Below are the various qualities that will meet the rigorous compounding requirements for those bulk sterile products unavailable by commercial means.

If an item furnished does not meet the requirement the item will be returned at the vendor's expense for a full refund.

a. The Contractor shall deliver orders to CRDAMC within four (4) business days (Monday through

Friday not including Federal Holidays) from receiving the order.

b. The Contractor shall have at a minimum one (1) year experience in Compound Pharmaceutical manufacturing.

c. The Contractor shall provide compounded pharmaceuticals meeting or exceeding the minimum shelf life listed in the below Pharmaceutical Drug List while stored at specified room temperature or refrigerated.

d. The Contractor shall be in compliant with Trade Agreements Act (TAA) (ingredients supplied from authorized sources).

e. FDA allows +/- 15%, however, the Contractor shall delivery pharmaceuticals within +/- 10%.

f. The Contractor shall be in compliant with Compounding Quality Act Title I of the Drug Quality and

Security Act of 2013.

g. The Contractor shall be in compliant with Current Good Manufacturing Practices (CGMP) (section

501(a)(2)(B).

h. The Contractor shall Label with adequate directions for use (CGMP) requirements under (section

502(f)(1) and make any modification to the packing and labeling of product if CRDAMC requests due to patient safety concerns.

i. The contractor shall comply with all the requirements for facilities that compound drugs (cGMPs requirement under section 503B).

i. The Contractor shall have Food and Drug Administration (FDA) approval prior to marketing

(CGMP) (section 505).

j. The Contractor shall provide QI/QA certification on every batch regardless of size.

k. The contractor must comply with all DEA Licensing requirements for the manufacturing and distribution of controlled substance to the facility.

l. Documented proof for item #1 listed below must accompany the RFQ, in order to be considered for award; additionally the vendor must be in compliance with items #2 and #3 below:

1. Certification/Accreditations: FDA or Pharmacy Compounding Accreditation Board

(PCAB) certification. The company will have an active certification which will be maintained annually to ensure the products are conducted with strict adherence to quality standards and principles of professional compounding.

2. USP Chapter <797>: The pharmacy must be compliant with ongoing changes and keeping up to date with requirements imposed by USP Chapter <797>. Products made are performed under the guidance set forth by this organization.

3. Quality Control: A system of quality checks which include environmental monitoring, raw material testing, in-process testing, endotoxin testing, product sterility and fungal testing as well as potency and stability testing of finished preparations. May conduct studies to verify and potentially extend the stability and use-by dating on all preparations. Vendor shall provide QI/QA certification on every batch regardless of size.

PHARMACEUTICAL DRUG LIST

(With minimum shelf life and storage requirements)

Line Item 0001: Hydromorphone 0.2mg/ml in 0.9% NS in 30ml PCA vial, NDC# 45183070268, (minimum shelf life: 45 days, at room temperature)

Line Item 0002: Succinylcholine 20mg/ml Syringes 5ml, NDC# 45183010470, (minimum shelf life: 45 days, at room temperature)

Line Item 0003: Ephedrine 5mg/ml in 0.9% NS 5ml Syringes, NDC# 45183093970, (minimum shelf life: 45 days, at room temperature)

Line Item 0004: Fentanyl 50mcg/ml in 50ml bag, NDC# 45183082168, (minimum shelf life: 60 days, at room temperature)

Line Item 0005: Ketamine 50mg/ml in 5ml syringe, NDC# (minimum shelf life: 45 days, at room temperature)

Line Item 0006: Ropivacaine 0.2% in 100ML CADD Cassette, NDC# 45183051148, (minimum shelf life: 45 days, at room temperature)

Line Item 0007: Lidocaine, Epinephrine, Tetracaine L.E.T. Solution Thick Gel 1.5ML Syringe, NDC#

Compounded Product, (minimum shelf life: 30 days, refrigerated)

Line Item 0008: Progesterone Suppositories 50MG, NDC# Compounded Product, (minimum shelf life: 60 days, refrigerated)

Line Item 0009: Oxytocin 30Units in Lactated Ringers in 500ml bag, NDC# 00338-0049-03, (minimum shelf life: 30 days, at room temperature)

Line Item 0010: Ropivacaine 0.2% with Fentanyl 2MCG/ML in 100ML Yellow CADD Cassette, NDC#

45183050641, (minimum shelf life: 45 days, at room temperature)

Technical Acceptability: Each factor must be found technically acceptable in order to be eligible for award.

Acceptable: Documentation provided clearly meets the minimum requirements of the solicitation.

Unacceptable: Documentation provided does not meet the minimum requirements of the solicitation

Any technical factor rated technically unacceptable makes the offeror ineligible for award.

2. Past Performance: The Government may consider any past performance information that is available to the Government, FDA, from its own files, databases such as the Past Performance Information Retrieval System

(PPIRS), or from any other source it deems appropriate.

This information will be used to determine the degree of confidence the Government has in the ability of the offeror to perform the requirement of this procurement.

This factor will be rated as either “acceptable” or “unacceptable”.

Table A-2. Past Performance Evaluation Ratings

Rating Description

Acceptable Based on the offeror’s performance record, the

Government has a reasonable expectation that the offeror will successfully perform the required effort, or the offeror’s performance record is unknown.

Unacceptable Based on the offeror’s performance record, the

Government has no reasonable expectation that the offeror will be able to successfully perform the required effort.

3. Price: Price will be evaluated using various price analysis techniques and procedures IAW FAR

15.404-1(b) including, but not limited to, comparison of proposed price received in response to the solicitation with a comparison to the Independent Government Estimate (IGE). Evaluation of price will include a determination that the price is fair and reasonable.

(b). Options. The Government will evaluate proposals for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that a proposal is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s).

(c). Given that FAR 52.217-8 provides that the Government may exercise the Option to Extend Services at the rates specified in the contract (i.e., the rates in effect when the Extension of Services option is exercised), for purposes of evaluating the Option to Extend Services, the Contracting Officer will consider the prices submitted for the base year and each option year, since those are the binding prices should the Option to Extend be exercised.

(d). Quotes must be submitted NLT the offer due date/local time CST by e-mailing or faxing to:

timothy.t.hoerz.civ@mail.mil, or faxing to (254) 553-3906 Attn: Tim Hoerz. No telephonic questions will be accepted, only through email. A signed SF form 1449 with completed pricing data must be submitted. E-mail is the preferred method.

(e). Evaluation Process: All offers will be evaluated IAW FAR 15.305 first: Award will be made using the lowest-price, technically-acceptable source selection process. The Government will initially list proposals from lowest to highest price. If a proposal is rated Technically Unacceptable, the Government will not evaluate any other factor.

USING THIS PROCEDURE, THE GOVERNMENT MIGHT NOT EVALUATE ALL PROPOSALS. Proposals receiving a rating of “less than adequate” or “not acceptable” will not be eligible for award.

(f). A written notice of award or acceptance of an offer, will be furnished via e-mail to the successful offeror within the time for acceptance specified in the offer and shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.

(end of provision)

52.209-2 PROHIBITION ON CONTRACTING WITH INVERTED DOMESTIC CORPORATIONS--

REPRESENTATION (NOV 2015)

(a) Definitions. Inverted domestic corporation and subsidiary have the meaning given in the clause of this contract entitled Prohibition on Contracting with Inverted Domestic Corporations (52.209-10).

(b) Government agencies are not permitted to use appropriated (or otherwise made available) funds for contracts with either an inverted domestic corporation, or a subsidiary of an inverted domestic corporation, unless the exception at 9.108-2(b) applies or the requirement is waived in accordance with the procedures at 9.108-4.

(c) Representation. The Offeror represents that--

(1) It [ ___ ] is, [ ___ ] is not an inverted domestic corporation; and mailto:timothy.t.hoerz.civ@mail.mil

(2) It [ ___ ] is, [ ___ ] is not a subsidiary of an inverted domestic corporation.

(End of provision)

52.209-10 Prohibition on Contracting With Inverted Domestic Corporations. (NOV 2015)

(a) Definitions. As used in this clause--

Inverted domestic corporation means a foreign incorporated entity that meets the definition of an inverted domestic corporation under 6 U.S.C. 395(b), applied in accordance with the rules and definitions of

6 U.S.C. 395(c).

Subsidiary means an entity in which more than 50 percent of the entity is owned--

(1) Directly by a parent corporation; or

(2) Through another subsidiary of a parent corporation.

(b) If the contractor reorganizes as an inverted domestic corporation or becomes a subsidiary of an inverted domestic corporation at any time during the period of performance of this contract, the Government may be prohibited from paying for Contractor activities performed after the date when it becomes an inverted domestic corporation or subsidiary. The Government may seek any available remedies in the event the Contractor fails to perform in accordance with the terms and conditions of the contract as a result of Government action under this clause.

(c) Exceptions to this prohibition are located at 9.108-2.

(d) In the event the Contractor becomes either an inverted domestic corporation, or a subsidiary of an inverted domestic corporation during contract performance, the Contractor shall give written notice to the Contracting

Officer within five business days from the date of the inversion event.

(End of clause)

52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000)

(a) The Government may extend the term of this contract by written notice to the Contractor within 15 calendar days; before the contract expires provided that the Government gives the Contractor a preliminary written notice of its intent to extend at least 60 calendar days before the contract expires. The preliminary notice does not commit the

Government to an extension.

(b) If the Government exercises this option, the extended contract shall be considered to include this option clause.

(c) The total duration of this contract, including the exercise of any options under this clause, shall not exceed 39 months.

52.219-28 POST-AWARD SMALL BUSINESS PROGRAM REREPRESENTATION (JULY 2013)

(a) Definitions. As used in this clause--

Long-term contract means a contract of more than five years in duration, including options. However, the term does not include contracts that exceed five years in duration because the period of performance has been extended for a cumulative period not to exceed six months under the clause at 52.217-8, Option to Extend Services, or other appropriate authority.

Small business concern means a concern, including its affiliates, that is independently owned and operated, not dominant in the field of operation in which it is bidding on Government contracts, and qualified as a small business under the criteria in 13 CFR part 121 and the size standard in paragraph (c) of this clause. Such a concern is ``not dominant in its field of operation'' when it does not exercise a controlling or major influence on a national basis in a kind of business activity in which a number of business concerns are primarily engaged. In determining whether dominance exists, consideration shall be given to all appropriate factors, including volume of business, number of employees, financial resources, competitive status or position, ownership or control of materials, processes, patents, license agreements, facilities, sales territory, and nature of business activity.

(b) If the Contractor represented that it was a small business concern prior to award of this contract, the Contractor shall rerepresent its size status according to paragraph (e) of this clause or, if applicable, paragraph (g) of this clause, upon the occurrence of any of the following:

(1) Within 30 days after execution of a novation agreement or within 30 days after modification of the contract to include this clause, if the novation agreement was executed prior to inclusion of this clause in the contract.

(2) Within 30 days after a merger or acquisition that does not require a novation or within 30 days after modification of the contract to include this clause, if the merger or acquisition occurred prior to inclusion of this clause in the contract.

(3) For long-term contracts--

(i) Within 60 to 120 days prior to the end of the fifth year of the contract; and

(ii) Within 60 to 120 days prior to the date specified in the contract for exercising any option thereafter.

(c) The Contractor shall rerepresent its size status in accordance with the size standard in effect at the time of this rerepresentation that corresponds to the North American Industry Classification System (NAICS) code assigned to this contract. The small business size standard corresponding to this NAICS code can be found at http://www.sba.gov/content/table-small-business-size-standards.

(d) The small business size standard for a Contractor providing a product which it does not manufacture itself, for a contract other than a construction or service contract, is 500 employees.

(e) Except as provided in paragraph (g) of this clause, the Contractor shall make the representation required by paragraph (b) of this clause by validating or updating all its representations in the Representations and Certifications section of the System for Award Management (SAM) and its other data in SAM, as necessary, to ensure that they reflect the Contractor's current status. The

Contractor shall notify the contracting office in writing within the timeframes specified in paragraph (b) of this clause that the data have been validated or updated, and provide the date of the validation or update.

(f) If the Contractor represented that it was other than a small business concern prior to award of this contract, the

Contractor may, but is not required to, take the actions required by paragraphs (e) or (g) of this clause.

(g) If the Contractor does not have representations and certifications in SAM, or does not have a representation in

SAM for the NAICS code applicable to this contract, the Contractor is required to complete the following rerepresentation and submit it to the contracting office, along with the contract number and the date on which the rerepresentation was completed:

The Contractor represents that it ( ) is, ( ) is not a small business concern under NAICS Code 325412- assigned to contract number .

(Contractor to sign and date and insert authorized signer's name and title).

52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es):

http://farsite.hill.af.mil/

52.252-6 AUTHORIZED DEVIATIONS IN CLAUSES (APR 1984)

(a) The use in this solicitation or contract of any Federal Acquisition Regulation (48 CFR Chapter 1) clause with an authorized deviation is indicated by the addition of "(DEVIATION)" after the date of the clause.

(b) The use in this solicitation or contract of any DoD FAR Supplement (48 CFR Chapter 2) clause with an authorized deviation is indicated by the addition of "(DEVIATION)" after the name of the regulation.

252.204-7012 SAFEGUARDING COVERED DEFENSE INFORMATION AND CYBER INCIDENT

REPORTING (DEVIATION 2016-O0001)(OCT 2015)

(a) Definitions. As used in this clause—

“Adequate security” means protective measures that are commensurate with the consequences and probability of loss,…